Compare
Healthstream Inc vs Health Catalyst, Inc. vs PubMatic, Inc. vs Yalla Group Ltd
| Latest fiscal year | Healthstream Inc HSTM | Health Catalyst, Inc. HCAT | PubMatic, Inc. PUBM | Yalla Group Ltd YALA |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $304.06M | $311.14M | $282.93M | $341.94M |
| Revenue growth (YoY) | +4.3% | +1.5% | -2.9% | +0.7% |
| Gross margin | n/a | n/a | 63.6% | 67.3% (computed) |
| Operating margin | 6.7% | -51.7% | -6.1% | 35.7% |
| Net margin | 6.0% | -57.2% | -5.1% | 43.3% |
| Net income | $18.34M | -$177.97M | -$14.46M | $148.14M |
| EPS (Diluted) | $0.61 | -$2.55 | -$0.31 | $0.83 |
| Operating cash flow | $63.32M | $731.0K | $81.06M | $137.54M |
| Free cash flow | $59.63M | -$237.0K | $66.71M | $135.56M |
| Cash & equivalents | $36.16M | $50.81M | $145.52M | $526.97M |
| Total assets | $520.37M | $502.64M | $680.20M | $896.22M |
| Total liabilities | n/a | $256.86M | $417.61M | $94.17M |
| Shareholders' equity | $354.02M | $245.78M | $262.59M | $810.28M |
| Return on year-end equity | 5.2% | -72.4% | -5.5% | 18.3% |
| Shares outstanding | 29.58M | 72.03M | n/a | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Healthstream Inc | Health Catalyst, Inc. | PubMatic, Inc. | Yalla Group Ltd |
|---|---|---|---|---|
| Latest | $304.06M Ended 2025-12-31 | $311.14M Ended 2025-12-31 | $282.93M Ended 2025-12-31 | $341.94M Ended 2025-12-31 |
| 1 year earlier | $291.65M Ended 2024-12-31 | $306.58M Ended 2024-12-31 | $291.26M Ended 2024-12-31 | $339.68M Ended 2024-12-31 |
| 2 years earlier | $279.06M Ended 2023-12-31 | $295.94M Ended 2023-12-31 | $267.01M Ended 2023-12-31 | $318.88M Ended 2023-12-31 |
| 3 years earlier | $266.83M Ended 2022-12-31 | $276.24M Ended 2022-12-31 | $256.38M Ended 2022-12-31 | $303.60M Ended 2022-12-31 |
| 4 years earlier | $256.71M Ended 2021-12-31 | $241.93M Ended 2021-12-31 | $226.91M Ended 2021-12-31 | $273.13M Ended 2021-12-31 |